XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
Stock-based compensation expense for each employee and director is presented in the same statement of operations caption as their cash compensation. Stock-based compensation expense by statement of operations caption and the related income tax benefit were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(In thousands)
2018
 
2017
 
2018
 
2017
Cost of sales
$
21

 
$
19

 
$
61

 
$
53

Research and development expenses
200

 
149

 
556

 
412

Selling, general and administrative expenses:
 
 
 
 
 
 
 
Employees
1,671

 
1,843

 
4,936

 
5,562

Outside directors
247

 
1,910

 
1,255

 
3,449

Total employee and director stock-based compensation expense
$
2,139


$
3,921


$
6,808


$
9,476

 
 
 
 
 
 
 
 
Income tax benefit
$
441

 
$
603

 
$
1,423

 
$
2,307



Stock Options

Stock option activity was as follows:
 
Number of Options
(in 000's)
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
(in years)
 
Aggregate Intrinsic Value
(in 000's)
Outstanding at December 31, 2017
520

 
$
42.56

 
 
 
 
Granted
119

 
44.95

 
 
 
 
Exercised
(35
)
 
24.67

 
 
 
$
744

Forfeited/canceled/expired
(7
)
 
27.74

 
 
 
 
Outstanding at September 30, 2018 (1)
597

 
$
44.27

 
4.34
 
$
2,972

Vested and expected to vest at September 30, 2018 (1)
597

 
$
44.27

 
4.34
 
$
2,972

Exercisable at September 30, 2018 (1)
414

 
$
41.74

 
3.64
 
$
2,972

(1) 
The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the third quarter of 2018 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on September 30, 2018. This amount will change based on the fair market value of our stock.
The assumptions we utilized in the Black-Scholes option pricing model and the resulting weighted average fair value of stock option grants were the following:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Weighted average fair value of grants
$

 
$

 
$
14.26

 
$
19.61

Risk-free interest rate
%
 
%
 
2.51
%
 
1.75
%
Expected volatility
%
 
%
 
33.09
%
 
34.25
%
Expected life in years
0.00

 
0.00

 
4.53

 
4.52


As of September 30, 2018, we expect to recognize $2.3 million of total unrecognized pre-tax stock-based compensation expense related to non-vested stock options over a remaining weighted-average life of 1.9 years.
Restricted Stock
Non-vested restricted stock award activity was as follows:
 
Shares
(in 000's)
 
Weighted-Average Grant Date Fair Value
Non-vested at December 31, 2017
162

 
$
61.19

Granted
167

 
42.65

Vested
(75
)
 
60.02

Forfeited
(11
)
 
55.94

Non-vested at September 30, 2018
243

 
$
49.03


As of September 30, 2018, we expect to recognize $8.8 million of total unrecognized pre-tax stock-based compensation expense related to non-vested restricted stock awards over a weighted-average life of 1.8 years.